Cic Wealth, LLC Bristol Myers Squibb CO Transaction History

Cic Wealth, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $12,742 - $14,147	-200 Reduced 5.9%	3,191 $204 Million
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $30,752 - $34,880	468 Added 16.01%	3,391 $235 Million
Q4 2022 Feb 15, 2023	BUY	$68.48 - $81.09 $200,167 - $237,026	2,923 New	2,923 $210 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cic Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Cic Wealth, LLC with notifications on news.